Quality assurance of dosimetry and the impact on sample size in randomized clinical trials
Authors:
- Edwin AirdEAEdwin Aird
- Dag R. OlsenDODag R. Olsen
- 1 February 2008
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 86 (2) , 195-199
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A randomised trial of accelerated radiotherapy for localised invasive bladder cancerRadiotherapy and Oncology, 2005
- Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trialRadiotherapy and Oncology, 2005
- Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancerRadiotherapy and Oncology, 2004
- The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trialRadiotherapy and Oncology, 2004
- Sample Size Calculations for Randomized Controlled TrialsEpidemiologic Reviews, 2002
- Accurate in vivo dosimetry of a randomized trial of prostate cancer irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Radiobiological modeling and clinical trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- The implementation of in vivo dosimetry in a small radiotherapy departmentRadiotherapy and Oncology, 1998
- Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapyRadiotherapy and Oncology, 1998
- Radiobiological considerations in the design of clinical trialsRadiotherapy and Oncology, 1994